Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksModel.php on line 57

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Settings.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Keyphrases.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Statistics.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Modules.php on line 16
alimta pemetrexed mesothelioma



Data Affirm Benefit of ALIMTA(R) (pemetrexed for injection) for Patients with Non-Small Cell Lung Cancer (Press Trust of India)

The clinical benefit of ALIMTA(R) (pemetrexed for injection) continues to be validated across patient populations, as demonstrated in two studies conducted in Asia. The data presented today at the 12th World Conference on Lung Cancer provide further support of the efficacy of Eli Lilly and Company’s ALIMTA in treating non-small cell lung cancer (NSCLC), the world’s most common form of cancer.(1) …

More: continued here




   Posted in mesothelioma    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply